Corient Private Wealth’s Nomura Holdings NMR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1M Buy
114,118
+10,088
+10% +$83.9K ﹤0.01% 1816
2026
Q1
$798K Buy
104,030
+17,837
+21% +$154K ﹤0.01% 1774
2025
Q4
$723K Buy
86,193
+24,656
+40% +$184K ﹤0.01% 1670
2025
Q3
$447K Buy
61,537
+3,508
+6% +$24.6K ﹤0.01% 1858
2025
Q2
$382K Buy
58,029
+2,697
+5% +$15.8K ﹤0.01% 1854
2025
Q1
$340K Sell
55,332
-18,110
-25% -$115K ﹤0.01% 1793
2024
Q4
$425K Sell
73,442
-8,152
-10% -$46.3K ﹤0.01% 1705
2024
Q3
$426K Buy
81,594
+4,098
+5% +$23.3K ﹤0.01% 1827
2024
Q2
$448K Sell
77,496
-5,711
-7% -$33.8K ﹤0.01% 1705
2024
Q1
$534K Sell
83,207
-8,865
-10% -$49.2K ﹤0.01% 1595
2023
Q4
$415K Sell
92,072
-13,419
-13% -$55.2K ﹤0.01% 1703
2023
Q3
$421K Buy
105,491
+24,255
+30% +$96.6K ﹤0.01% 1579
2023
Q2
$311K Sell
81,236
-43,519
-35% -$161K ﹤0.01% 1678
2023
Q1
$474K Buy
124,755
+61,189
+96% +$242K ﹤0.01% 1404
2022
Q4
$238K Buy
+63,566
New +$220K ﹤0.01% 1425

Other funds holding NMR

Corient Private Wealth's NMR Position: Q2 2026 in Review

Corient Private Wealth increased its Nomura Holdings (NMR) stake by 9.7% in Q2 2026, buying an estimated $83.9K and bringing the position to 114,118 shares worth $1M. The position accounts for ﹤0.01% of the portfolio, ranked #1816.

Corient Private Wealth first reported a position in NMR in Q4 2022 and has held it in 15 quarters since. 300 funds tracked by Wall St. Rank hold NMR as of Q2 2026.

  • Corient Private Wealth held 114,118 shares of Nomura Holdings worth $1M as of Q2 2026.
  • Corient Private Wealth bought 10,088 Nomura Holdings shares in Q2 2026, an estimated $83.9K.
  • Nomura Holdings made up ﹤0.01% of Corient Private Wealth's portfolio in Q2 2026, its #1816 holding.
  • Corient Private Wealth first reported a position in Nomura Holdings in Q4 2022 and has held it in 15 quarters since.
  • 300 funds tracked by Wall St. Rank held Nomura Holdings as of Q2 2026.

Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.